1180486-34-3

Basic information

• Product Name: N-[3-[2-(5,6-diethoxy-7-fluoro-1-imino-1,3-dihydroisoindol-2-yl)acetyl]-5-(pentafluorosulfanyl)phenyl]acetamide hydrobromide
• Synonyms: N-[3-[2-(5,6-diethoxy-7-fluoro-1-imino-1,3-dihydroisoindol-2-yl)acetyl]-5-(pentafluorosulfanyl)phenyl]acetamide hydrobromide
• CAS NO: 1180486-34-3
• Molecular Weight: 620.411
• Mol File: 1180486-34-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-[3-[2-(5,6-diethoxy-7-fluoro-1-imino-1,3-dihydroisoindol-2-yl)acetyl]-5-(pentafluorosulfanyl)phenyl]acetamide hydrobromide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[3-[2-(5,6-diethoxy-7-fluoro-1-imino-1,3-dihydroisoindol-2-yl)acetyl]-5-(pentafluorosulfanyl)phenyl]acetamide hydrobromide(1180486-34-3)
• EPA Substance Registry System: N-[3-[2-(5,6-diethoxy-7-fluoro-1-imino-1,3-dihydroisoindol-2-yl)acetyl]-5-(pentafluorosulfanyl)phenyl]acetamide hydrobromide(1180486-34-3)

Safety Data

• Hazardous Substances Data: 1180486-34-3(Hazardous Substances Data)

Upstream product

• 1180487-06-2 1-[3-amino-5-(pentafluorosulfanyl)phenyl]ethanone trifluoroacetate 
• 1178585-39-1 N-methoxy-N-methyl-5-nitro-3-pentafluorosulfanylbenzamide 
• 1178585-41-5 N-[3-acetyl-5-(pentafluorosulfanyl)phenyl]acetamide 
• 1005515-04-7 N-methoxy-N-methyl-3-(pentafluorosulfanyl)-5-(2,2,2-trifluoroacetylamino)benzamide 
• 1005515-03-6 3-amino-N-methoxy-N-methyl-5-pentafluorosulfanylbenzamide 
• 852469-45-5 3-nitro-5-(pentafluoro-λ⁶-sulfanyl)benzoic acid 
• 833-96-5 3-(pentafluoro-λ⁶-sulphanyl)benzoic acid 
• 474554-46-6 5,6-diethoxy-7-fluoro-3H-isoindol-1-ylamine 
• 1178584-06-9 N-[3-(2-bromoacetyl)-5-(pentafluorosulfanyl)phenyl]acetamide 

Relevant articles and documents

SF5 DERIVATIVES AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS MEDICAMENTS

The invention relates to novel compounds of formula I where R1, R2, R3, R4, R5, R9, Ar, Q1, Q2 and Q3 are each as defined below. The compounds of the formula I have antithrombotic activity and inhibit especially protease-activated receptor 1 (PAR1). The invention further relates to a process for preparing the compound of the formula I and to the use thereof as a medicament.